Orbis Biosciences Announces Licensing Agreement with Reckitt Benckiser

Orbis Biosciences optimizes oral and injectable pharmaceutical products for improved compliance. Orbis' proprietary technologies provide customized drug release, format and dose flexibility, and taste-masking for oral drugs.LENEXA, Kan., Jan. 3, 2018 /PRNewswire/ -- Orbis Biosciences, Inc. announced today that it has entered into an exclusive global license agreement leveraging its Precision Particle Fabrication® technology. Reckitt Benckiser (RB), world leading Consumer Healthcare company, and Orbis have...